Three point mutations in the mannose-binding lectin (MBL) gene are each known to reduce serum lectin levels and contribute to a deficiency of the MBL protein. In 1995, Madsen et al. (8) showed that additional mutations in the promoter region of the MBL gene play an additional role in reduced MBL levels. That paper reported the frequencies of the promoter haplotypes which regulate the expression of the peptide in populations of pure Eskimos, Caucasians, and black Africans and discussed their putative role.
This short report presents the genotypic data (gene and promoter variants) from a large family with three members who had acquired meningococcal meningitis in early childhood and the correlation between these genotypes and MBL concentrations in the sera (described in a recent report [1] ).
EDTA blood samples were collected from all known members of the family, followed by genomic DNA isolation using a commercially available isolation kit according to the manufacturer's instructions (QIAamp DNA Blood Mini kit; QIAGEN, Hilden, Germany). Genomic PCRs were performed in 50-l volumes containing primers specific for the alleles described by Madsen et al. (8) in the exon 1 region (wild-type A and the variant alleles B, C, and D). The same was done for the variant alleles in the promoter region of the MBL gene: H and L, X and Y. DNA was amplified as described by Madsen et al. (7, 8) , using general PCR and site-directed mutagenesis PCR for types A, B, C, and D and PCR with sequence-specific priming for types H/L and X/Y. Wild-type (type A) and B, C, and D alleles were distinguished by restriction enzyme digestions of the PCR products (7, 8) . The cis/trans locations of the promoter variants H/L and X/Y relative to the structural variants A, B, C, and D were determined as well. Madsen and colleagues stressed in their report (8) that all of their attempts to use the PCR with sequence-specific priming technique in typing the H allele had failed. We, in contrast, succeeded by using the primer 5Ј-TTA-CCC-AGG-CAA-GCC-TGT-G-3Ј and 40 cycles of 30 s at 94°C, 60 s at 68°C, and 60 s at 72°C (see Fig.  1 ).
MBL concentrations in serum samples of the family members were measured using a functional MBL assay (6) with purified wild-type MBL as a reference protein (a kind gift from P. Garred, Statens Serum Institute, Copenhagen, Denmark) as previously described (1) .
Three variants of polymorphism in the coding region of the Fig. 2 ). In addition, the HY, LY, and LX haplotypes correlated with different levels of serum MBL: HY with high, LY with intermediate, and LX with low levels. It is remarkable that variants in the promoter region (LX associated with wild-type A) correlate with relative low levels of functional MBL in heterozygotes for MBL codon variants.
Results of clinical studies have shown associations between MBL mutations and susceptibility to infection in patients with systemic lupus erythematosus (3), increased episodes of acute respiratory infection (5), and risk of invasive pneumococcal disease (10) and meningococcal disease (4). MBL deficiency is also associated with severe atherosclerosis (9) and risk of miscarriage (2).
In conclusion, earlier (Lancet) data (1) and our group's recent genotypic findings, mentioned here, indicate that MBL genotypes match their corresponding phenotypes, suggesting that MBL phenotyping (6) can be used to provisionally identify MBL-deficient subjects in a human population. 
